Edition:
United States

Bio-Techne Corp (TECH.OQ)

TECH.OQ on NASDAQ Stock Exchange Global Select Market

165.58USD
15 Jun 2018
Change (% chg)

-- (--)
Prev Close
$165.58
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
73,707
52-wk High
$166.47
52-wk Low
$109.52

Chart for

About

Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through three segments: Biotechnology, Clinical Controls and Protein Platforms. The Biotechnology segment develops, manufactures and sells biotechnology research... (more)

Overall

Beta: 0.75
Market Cap(Mil.): $6,221.48
Shares Outstanding(Mil.): 37.57
Dividend: 0.32
Yield (%): 0.77

Financials

  TECH.OQ Industry Sector
P/E (TTM): 77.27 240.92 34.18
EPS (TTM): 2.14 -- --
ROI: 5.51 -5.87 13.17
ROE: 8.24 -7.71 15.15

BRIEF-Bio-Techne Q3 GAAP Earnings Per Share $0.52

* Q3 EARNINGS PER SHARE VIEW $1.14 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

May 02 2018

BRIEF-Bio-Techne Q2 GAAP Earnings Per Share $1.29

* QTRLY GAAP EPS SAW A ONE-TIME BENEFIT OF $0.94 FROM TAX REFORM Source text for Eikon: Further company coverage:

Feb 06 2018

BRIEF-Bio-Techne Acquires Atlanta Biologicals Inc

* BIO-TECHNE CORP - ‍TRANSACTION IS FINANCED THROUGH AVAILABLE CASH ON HAND​

Jan 02 2018

Earnings vs. Estimates